Endpoints News 6 déc. 2025 Apple Tree Partners scores legal win against alleged holdout Russian investor
Endpoints News 6 déc. 2025 ACIP vote, more FDA turnover; Introducing Endpoints Signal; ARCH, Parker Institute building next cancer bet; and more
Endpoints News 6 déc. 2025 ORIC’s lung cancer pill shows promise in some settings but is dropped for HER2 mutations
Endpoints News 5 déc. 2025 Denali drug hold; Intercept layoffs; Capital raises for Immatics, Capricor and Protara
Endpoints News 5 déc. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News 5 déc. 2025 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme
Endpoints News 5 déc. 2025 Ex-Intercept CEO takes over at Altimmune; Carolyn Bertozzi leaves Alnylam's board
Endpoints News 4 déc. 2025 Prasad's claim of 10 Covid vaccine deaths may be an overcount: FDA sources
Endpoints News 4 déc. 2025 Trump administration pushes end-of-term deadline for ‘most favored nation’ promises
Endpoints News 4 déc. 2025 UniQure restates FDA's negative feedback on Huntington's trial; Neurimmune's expanded AstraZeneca alliance